Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017

BOCA RATON, Fla., Jan. 19, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
READ MORE

Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th - 11th in San Francisco

BOCA RATON, Fla., Jan. 3, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, CEO and Arthur Levine, CFO will participate in the Annual JP Morgan Healthcare […]
READ MORE

Sensus Healthcare Receives the BioFlorida Company of the Year Award

BOCA RATON, Fla., Dec. 13, 2016 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today that it has been named the winner of the BioFlorida Company of the Year Award at […]
READ MORE

Sensus Healthcare to Participate in Two Upcoming Investor Conferences on November 30th and December 1st

-- Evercore ISI MedTools Investor Conference in Boston, MA -- Drexel Hamilton's Emerging Growth Conference in New York, NY BOCA RATON, Fla., Nov. 16, 2016 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), […]
READ MORE

Sensus Healthcare Reports Third Quarter 2016 Results

- Q3 revenues increased 58% year-over-year to $3.33 million - Worldwide installed base increased to 256 units BOCA RATON, Fla., Nov. 3, 2016 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today reported […]
READ MORE

Sensus Healthcare to Announce Third Quarter 2016 Results on November 3, 2016

BOCA RATON, Fla., Oct. 20, 2016 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its third quarter 2016 financial results on Thursday, November 3, 2016 after the market […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected] Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.